These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 28369177)
1. A Simple and Direct LC-MS Method for Determination of Genotoxic Impurity Hydroxylamine in Pharmaceutical compounds. Kumar T; Ramya M; Srinivasan V; Xavier N J Chromatogr Sci; 2017 Aug; 55(7):683-689. PubMed ID: 28369177 [TBL] [Abstract][Full Text] [Related]
2. A High-Performance Liquid Chromatography Method for Determination of Genotoxic Impurity Hydroxylamine in Drug Substances. Kumar T; Xavier N; Ramya M J Chromatogr Sci; 2019 Jan; 57(1):63-70. PubMed ID: 30371764 [TBL] [Abstract][Full Text] [Related]
3. A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials. Wang J; Yang S; Zhang K J Pharm Biomed Anal; 2016 Jul; 126():141-7. PubMed ID: 27208624 [TBL] [Abstract][Full Text] [Related]
4. Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS. Venugopal N; Bhaskar Reddy AV; Gangadhar Reddy K; Madhavi V; Madhavi G J Pharm Biomed Anal; 2012 Nov; 70():592-7. PubMed ID: 22749172 [TBL] [Abstract][Full Text] [Related]
5. Determination of genotoxic impurity in atazanavir sulphate drug substance by LC-MS. K GB; K BMK; N S; D R; N VVSSR; B HB J Pharm Biomed Anal; 2017 Jan; 132():156-158. PubMed ID: 27723524 [TBL] [Abstract][Full Text] [Related]
6. A new liquid chromatography-mass spectrometry approach for generic screening and quantitation of potential genotoxic alkylation compounds without derivatization. Cappiello A; Famiglini G; Palma P; Termopoli V; Trufelli H J Chromatogr A; 2012 Sep; 1255():286-90. PubMed ID: 22226454 [TBL] [Abstract][Full Text] [Related]
7. Development of an LC-MS method for ultra trace-level determination of 2,2,6,6-tetramethylpiperidine-1-oxl (TEMPO), a potential genotoxic impurity within active pharmaceutical ingredients. Pennington J; Cohen RD; Tian Y; Boulineau F J Pharm Biomed Anal; 2015 Oct; 114():488-92. PubMed ID: 25921639 [TBL] [Abstract][Full Text] [Related]
8. Determination of arylamines and aminopyridines in pharmaceutical products using in-situ derivatization and liquid chromatography-mass spectrometry. Vanhoenacker G; Dumont E; David F; Baker A; Sandra P J Chromatogr A; 2009 Apr; 1216(16):3563-70. PubMed ID: 18804773 [TBL] [Abstract][Full Text] [Related]
9. Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids. Székely G; Henriques B; Gil M; Ramos A; Alvarez C J Pharm Biomed Anal; 2012 Nov; 70():251-8. PubMed ID: 22841555 [TBL] [Abstract][Full Text] [Related]
10. Determination of epoxide impurity in sarpogrelate hydrochloride intermediate by UHPLC and column-switching liquid chromatography. Wang R; Zhu Z; Qiu X; Bai L; Guo W; Zuo L; Zhao T; Shan G J Pharm Biomed Anal; 2019 Sep; 174():57-62. PubMed ID: 31154094 [TBL] [Abstract][Full Text] [Related]
11. Applications of hyphenated LC-MS techniques in pharmaceutical analysis. Ermer J; Vogel M Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275 [TBL] [Abstract][Full Text] [Related]
12. A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis. van Wijk AM; Beerman B; Niederländer HA; Siebum AH; de Jong GJ Anal Bioanal Chem; 2011 May; 400(5):1375-85. PubMed ID: 21445660 [TBL] [Abstract][Full Text] [Related]
13. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. An J; Sun M; Bai L; Chen T; Liu DQ; Kord A J Pharm Biomed Anal; 2008 Nov; 48(3):1006-10. PubMed ID: 18687555 [TBL] [Abstract][Full Text] [Related]
14. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development. Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883 [TBL] [Abstract][Full Text] [Related]
15. Sensitive CE-MS analysis of potentially genotoxic alkylation compounds using derivatization and electrokinetic injection. van Wijk AM; Niederländer HA; van Ogten MD; de Jong GJ Anal Chim Acta; 2015 May; 874():75-83. PubMed ID: 25910449 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of LC-MS method for the determination of heptaethylene glycol monomethyl ether in benzonatate bulk drugs. Katakam LNR; Ettaboina SK; Marisetti VM Biomed Chromatogr; 2021 Jul; 35(7):e5096. PubMed ID: 33605444 [TBL] [Abstract][Full Text] [Related]
17. HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process. Douša M; Klvaňa R; Doubský J; Srbek J; Richter J; Exner M; Gibala P J Chromatogr Sci; 2016 Feb; 54(2):119-24. PubMed ID: 26223463 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV. Al-Sabti B; Harbali J Biomed Chromatogr; 2020 Nov; 34(11):e4930. PubMed ID: 32579716 [TBL] [Abstract][Full Text] [Related]
20. Ion chromatographic determination of trace hydroxylamine in waste streams generated by a pharmaceutical reaction process. Fernando PN; Egwu IN; Hussain MS J Chromatogr A; 2002 May; 956(1-2):261-70. PubMed ID: 12108660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]